Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL)
specific2
Centers
2
Active Trials
—
Cancer Funding
Top Centers for Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL)(2)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dartmouth Cancer CenterLebanon, NH NCI Comprehensive High-Volume Research Center | 75.0 |
| 2 | Stony Brook Cancer CenterStony Brook, NY High-Volume Research Center | 75.0 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →